0001209191-14-034300.txt : 20140515 0001209191-14-034300.hdr.sgml : 20140515 20140515171446 ACCESSION NUMBER: 0001209191-14-034300 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140513 FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALDER BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001423824 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11804 NORTH CREEK PARKWAY SOUTH CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 425-205-2900 MAIL ADDRESS: STREET 1: 11804 NORTH CREEK PARKWAY SOUTH CITY: BOTHELL STATE: WA ZIP: 98011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson Aaron CENTRAL INDEX KEY: 0001515825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36431 FILM NUMBER: 14848837 MAIL ADDRESS: STREET 1: C/O H.I.G. CAPITAL STREET 2: 1450 BRICKELL AVENUE, 31ST FLOOR CITY: MIAMI STATE: FL ZIP: 33131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-05-13 0 0001423824 ALDER BIOPHARMACEUTICALS INC ALDR 0001515825 Davidson Aaron C/O H.I.G. CAPITAL 1450 BRICKELL AVENUE, 31ST FLOOR MIAMI FL 33131 1 0 0 0 Common Stock 2014-05-13 4 C 0 2065581 A 2065581 I By H.I.G. Venture Partners II, L.P. Common Stock 2014-05-13 4 C 0 516395 A 516395 I By H.I.G. Ventures - Alder, LLC Series B Preferred Stock 2014-05-13 4 C 0 1342657 0.00 D Common Stock 1342657 0 I By H.I.G. Venture Partners II, L.P. Series C Preferred Stock 2014-05-13 4 C 0 404040 0.00 D Common Stock 404040 0 I By H.I.G. Venture Partners II, L.P. Series D Preferred Stock 2014-05-13 4 C 0 318884 0.00 D Common Stock 318884 0 I By H.I.G. Venture Partners II, L.P. Series B Preferred Stock 2014-05-13 4 C 0 335664 0.00 D Common Stock 335664 0 I By H.I.G. Ventures - Alder, LLC Series C Preferred Stock 2014-05-13 4 C 0 101010 0.00 D Common Stock 101010 0 I By H.I.G. Ventures - Alder, LLC Series D Preferred Stock 2014-05-13 4 C 0 79721 0.00 D Common Stock 79721 0 I By H.I.G. Ventures - Alder, LLC The preferred stock converted into common stock on a 1-for-1 basis upon the closing of the issuer's initial public offering and had no expiration date. Mr. Davidson is managing director of H.I.G. BioVentures, an affiliate of H.I.G. Venture Partners II, L.P. and H.I.G. Ventures - Alder, LLC. As a managing director of an affiliate of the H.I.G. Funds, Mr. Davidson shares voting and investment power over the shares held by the H.I.G. Funds and may be deemed to have indirect beneficial ownership of such shares. Mr. Davidson disclaims beneficial ownership of the shares held by the H.I.G. Funds except to the extent of any pecuniary interest therein. /s/ Claudia LaFollette, Attorney-in-Fact for Aaron Davidson 2014-05-15 EX-24.4_522827 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents that the undersigned hereby constitutes and appoints each of Randall C. Schatzman and Larry Benedict of Alder BioPharmaceuticals, Inc. (the "Company") and Julia Conway, Michael Pirog and Claudia LaFollette of Cooley LLP, signing individually, the undersigned's true and lawful attorneys-in fact and agents to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation thereunder; (2) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the SEC Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (3) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such Forms with the SEC and any stock exchange, self-regulatory association or any other authority; and (4) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by the attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney-in-fact may approve in the attorney-in-fact's discretion. The undersigned hereby grants to each such attorney in fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney in fact, or such attorney in fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is the Company assuming) any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the attorneys-in fact. This Power of Attorney revokes any other power of attorney that the undersigned has previously granted to representatives of the Company and Cooley LLP. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below. Dated: April 2, 2014 By: /s/ Aaron Davidson Aaron Davidson Signature Printed Name